Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
46.23
0.00 (0.00%)
At close: Nov 26, 2025, 1:00 PM EST
46.25
+0.02 (0.04%)
Pre-market: Nov 28, 2025, 4:02 AM EST
Collegium Pharmaceutical Market Cap
Collegium Pharmaceutical has a market cap or net worth of $1.46 billion as of November 28, 2025. Its market cap has increased by 40.81% in one year.
Market Cap
1.46B
Enterprise Value
2.11B
1-Year Change
40.81%
Ranking
Category
Stock Price
$46.23
Market Cap Chart
Since May 7, 2015, Collegium Pharmaceutical's market cap has increased from $242.20M to $1.46B, an increase of 503.38%. That is a compound annual growth rate of 18.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.46B | 58.16% |
| Dec 31, 2024 | 924.00M | -7.95% |
| Dec 29, 2023 | 1.00B | 28.87% |
| Dec 30, 2022 | 778.90M | 20.63% |
| Dec 31, 2021 | 645.70M | -6.79% |
| Dec 31, 2020 | 692.70M | 0.39% |
| Dec 31, 2019 | 690.00M | 20.86% |
| Dec 31, 2018 | 570.90M | -5.02% |
| Dec 29, 2017 | 601.10M | 34.93% |
| Dec 30, 2016 | 445.50M | -21.69% |
| Dec 31, 2015 | 568.90M | 134.89% |
| May 7, 2015 | 242.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 993.82B |
| Johnson & Johnson | 497.93B |
| AbbVie | 409.68B |
| UnitedHealth Group | 295.56B |
| AstraZeneca | 288.24B |
| Merck & Co. | 262.25B |
| Novartis AG | 248.38B |
| Thermo Fisher Scientific | 224.59B |